News blog
William Ransom
- BY: Andrew Hore |
- POSTED: 22/12/2010 |
Peter Gyllenhammar is building up a stake in natural pharmaceuticals supplier William Ransom, which recently announced its intention to leave Aim.
Gyllenhammar has bought an additional 500,000 shares, taking his stake from 3.52% to 4.5%. The stake went above 3% in the middle of November – one month before the plans were announced to cancel the quote.
Ransom plans to set up a new holding company as part of the process to cancel its Aim quotation. The share price has fallen since the announcement and that gave Gyllenhammar a buying opportunity. At 3.12p a share, William Ransom is valued at £2.64m.
It is unclear whether Gyllenhammar will back the board’s plans.
© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- Browse by issue
- All issues
- Popular tags
- All tags
- AIM Micro feeds
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds
|